Related Experiment Video
Updated: Jun 25, 2026
02:55
Arteriovenous Metabolomics to Measure In Vivo Metabolite Exchange in Brown Adipose Tissue
Published on: October 6, 2023
Hypoadiponectinemia: a risk factor for metabolic syndrome.
Olly Renaldi1, Bowo Pramono, Hemi Sinorita
1Department of Internal Medicine, Gadjah Mada University, Yogyakarta, Indonesia.
Acta Medica Indonesiana
|March 5, 2009
Summary
Low adiponectin (hypoadiponectinemia) and insulin resistance are independent risk factors for developing metabolic syndrome. This study in Native Javanese people highlights their significance in metabolic syndrome development.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Human Physiology
Background:
- Metabolic syndrome is a cluster of conditions increasing the risk of heart disease, stroke, and type 2 diabetes.
- Adiponectin, a hormone produced by adipose tissue, plays a role in glucose regulation and fatty acid breakdown.
- Insulin resistance is a condition where cells fail to respond normally to the hormone insulin.
Purpose of the Study:
- To investigate the correlation between plasma adiponectin levels, insulin resistance, and the International Diabetes Federation (IDF) criteria for metabolic syndrome.
- To determine if low adiponectin levels and insulin resistance are independent risk factors for metabolic syndrome.
Main Methods:
- A case-control study was conducted on 20-55 year old Native Javanese individuals.
- Cases were diagnosed with metabolic syndrome based on IDF criteria; controls were age- and sex-matched individuals without metabolic syndrome.
- Measurements included body mass index, waist circumference, triglycerides, HDL cholesterol, blood pressure, fasting blood glucose, HOMA index, and plasma adiponectin levels.
Main Results:
- Significant differences were observed between cases and controls in BMI, waist circumference, triglyceride, HDL cholesterol, systolic and diastolic blood pressure, fasting blood glucose, HOMA index, and adiponectin levels.
- Hypoadiponectinemia (low adiponectin) showed an odds ratio (OR) of 6.0 for metabolic syndrome.
- Insulin resistance showed an OR of 5.7 for metabolic syndrome, after adjusting for key metabolic parameters.
Conclusions:
- Hypoadiponectinemia is an independent risk factor for the development of metabolic syndrome.
- Insulin resistance is also an independent risk factor for metabolic syndrome development.
- These findings underscore the importance of monitoring adiponectin levels and insulin sensitivity in metabolic syndrome risk assessment.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...